Skip to content
Open access

Finerenone Alleviates Cardiac Microvascular Injury and Neutrophil Extracellular Traps Formation in Diabetic Cardiomyopathy via Regulating AKT1 Phosphorylation

Aug 2026 · Acta Physiologica · Vol 242 · 0 citations · 60 references
Medicine

Abstract

Diabetes mellitus is commonly featured with cardiac microvascular dysfunction and chronic low‐grade inflammation, contributing to the progression of diabetic cardiomyopathy (DCM). Finerenone confers cardio‐renal protection in diabetic settings, yet its underlying mechanisms remain incompletely defined.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.